150 related articles for article (PubMed ID: 29414453)
21. Hypoxic Challenge Testing (Fitness to Fly) in children with complex congenital heart disease.
Naqvi N; Doughty VL; Starling L; Franklin RC; Ward S; Daubeney PEF; Balfour-Lynn IM
Heart; 2018 Aug; 104(16):1333-1338. PubMed ID: 29444807
[TBL] [Abstract][Full Text] [Related]
22. Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing.
Burgess A; Goon K; Brannan JD; Attia J; Palazzi K; Oldmeadow C; Corte TJ; Glaspole I; Goh N; Keir G; Allan H; Chapman S; Cooper W; Ellis S; Hopkins P; Moodley Y; Reynolds P; Zappala C; Macansh S; Grainge C
Respirology; 2019 Oct; 24(10):988-995. PubMed ID: 30924257
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
24. Elevated nocturnal desaturation index predicts mortality in interstitial lung disease.
Corte TJ; Wort SJ; Talbot S; Macdonald PM; Hansel DM; Polkey M; Renzoni E; Maher TM; Nicholson AG; Wells AU
Sarcoidosis Vasc Diffuse Lung Dis; 2012 Mar; 29(1):41-50. PubMed ID: 23311122
[TBL] [Abstract][Full Text] [Related]
25. Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis.
Peckham D; Watson A; Pollard K; Etherington C; Conway SP
J Cyst Fibros; 2002 Dec; 1(4):281-6. PubMed ID: 15463828
[TBL] [Abstract][Full Text] [Related]
26. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
27. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study.
Khor YH; Gutman L; Abu Hussein N; Johannson KA; Glaspole IN; Guler SA; Funke-Chambour M; Geiser T; Goh NSL; Ryerson CJ
Chest; 2021 Sep; 160(3):994-1005. PubMed ID: 33905679
[TBL] [Abstract][Full Text] [Related]
28. Hypoxic challenge flight assessments in patients with severe chest wall deformity or neuromuscular disease at risk for nocturnal hypoventilation.
Mestry N; Thirumaran M; Tuggey JM; Macdonald W; Elliott MW
Thorax; 2009 Jun; 64(6):532-4. PubMed ID: 19318347
[TBL] [Abstract][Full Text] [Related]
29. Evaluating hypoxia during air travel in healthy infants.
Khanna M; Shackleton C; Verheggen M; Sharp M; Wilson AC; Hall GL
Thorax; 2013 Dec; 68(12):1163-4. PubMed ID: 23868331
[TBL] [Abstract][Full Text] [Related]
30. Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
Nurmi HM; Purokivi MK; Kärkkäinen MS; Kettunen HP; Selander TA; Kaarteenaho RL
BMC Pulm Med; 2017 Jan; 17(1):16. PubMed ID: 28086844
[TBL] [Abstract][Full Text] [Related]
31. Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Arthritis Rheumatol; 2017 Mar; 69(3):542-549. PubMed ID: 27788297
[TBL] [Abstract][Full Text] [Related]
32. Acute exacerbation of interstitial lung disease after procedures.
Amundson WH; Racila E; Allen T; Dincer HE; Tomic R; Bhargava M; Perlman DM; Kim HJ
Respir Med; 2019 Apr; 150():30-37. PubMed ID: 30961948
[TBL] [Abstract][Full Text] [Related]
33. Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices.
Jacob J; Bartholmai BJ; Rajagopalan S; Egashira R; Brun AL; Kokosi M; Nair A; Walsh SLF; Karwoski R; Nicholson AG; Hansell DM; Wells AU
Respir Med; 2017 Sep; 130():43-51. PubMed ID: 29206632
[TBL] [Abstract][Full Text] [Related]
34. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
35. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
[TBL] [Abstract][Full Text] [Related]
36. Predicting the response to air travel in passengers with non-obstructive lung disease: are the current guidelines appropriate?
Kelly PT; Swanney MP; Seccombe LM; Frampton C; Peters MJ; Beckert LE
Respirology; 2009 May; 14(4):567-73. PubMed ID: 19386067
[TBL] [Abstract][Full Text] [Related]
37. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.
Holland AE; Hill CJ; Glaspole I; Goh N; McDonald CF
Respir Med; 2012 Mar; 106(3):429-35. PubMed ID: 22182340
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
Callahan SJ; Xia M; Murray S; Flaherty KR
Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
[TBL] [Abstract][Full Text] [Related]
39. Derivation and Validation of a Diagnostic Prediction Tool for Interstitial Lung Disease.
Pugashetti JV; Kitich A; Alqalyoobi S; Maynard-Paquette AC; Pritchard D; Graham J; Boctor N; Kulinich A; Lafond E; Foster E; Mendez C; Choudhry S; Chalaoui J; Morisset J; Kadoch M; Oldham JM
Chest; 2020 Aug; 158(2):620-629. PubMed ID: 32184110
[TBL] [Abstract][Full Text] [Related]
40. Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease.
Chetta A; Aiello M; Foresi A; Marangio E; D'Ippolito R; Castagnaro A; Olivieri D
Sarcoidosis Vasc Diffuse Lung Dis; 2001 Jun; 18(2):170-5. PubMed ID: 11436537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
